Page 133 - Traité de Chimie Thérapeutique 4 Médicaments en relation avec des systèmes hormonaux

94 MÉDICAMENTS EN RELA DON A VEC DES SYSTÈMES HORMONA UX

Relations structure-activité
RUFER C. et LOSERT W., Blood glucose lowering sulfonamides with asymmetric car­
bon atoms. 3. Related /V-substitued carbamoylbenzoic acids. J. Med. Chem., 1979,
22, 750-752.
BROWN G.R. et FOUBISTER A.J., Receptor binding sites of hypoglycémie sulfonylu-
reasand related [(acylamino)alkyl]benzoïc acids, J. Med. Chem.,1984, 24, 79-81.
Herbicides
BLAIR A.M. et MARTIN T.D., A review of the activity, fate and mode of action of sulfo-
nylurea herbicides, Pestic. Sci., 1988, 22,195-219.
SCHLOSS J.V., Acetolactate synthase, mechanism of action and its herbicide binding
site. Pestic. Sci.,1990, 29, 283-292.
Diarylsulfonylurées à activité antitumorale
GRINDEY G.B. Identification of diarylsulfonylureas as novel anti cancer drugs. Proc.
Am. Assoc. Cancer. Res.,1988, 29, 535.
HOWBERT J.J., GROSSMAN C.S., CROWELL T.A., RIEDER B.J., HARPER R.W.,
KRAMER K.E...TAO E.V., AIKINS J., POORE G.A., RINZEL S.M., GRINDEY G.B.,
SHAW W.N. et TODD G.C., Novel agents effective against solid tumors : the diaryl­
sulfonylureas. Synthesis, activities and analysis of quantitative structure activity
relationships. J. Med. Chem., 1990, 33, 2393-2407.
HOUGHTON P.J., BAILEY F.C., GERMAIN G.S., GRINDEY G.B., HOWBERT
J.J. et HOUGHTON J.A., Studies on the cellular pharmacology of /V-(4-methylphe-
nylsulfonyl)-/V‘-(4-chlorophenyl)urea. Biochem. Pharmacol., 1990, 39, 1187-1192.
HOWBERT J.J., Sulofenur, Drugs ofthe Future, 1991,16, 517-520.
MOHAMADI F., SPEES M.M. et RINDEY G.B., Sulfonylureas : a new class of cancer
chemotherapeutic agents. J. Med. Chem., 1992, 35, 3012-3016.
BODER G.B., EHLHARDT W.J., GRINDEY G.B., HOUGHTON P.J., KAU D.L., MOHA­
MADI F., SELTZ D.E., SHAW W.N. et TOTH J.E., Discovery of novel antineoplastic
sulfonylureas, Drugs of the future, 1992,17, 1111-1114.
TOTH J.E., RAY J. et DEL I bR J., Synthesis and resolution of sulfonimidamide analogs
of sulfonylureas, J. Org. Chem., 1993, 58, 3469-3472.
Voies d’accès — Propriétés physico-chimiques
DOLLERY C., (edit) in Therapeutic drugs CHURCHILL LIVINGSTONE, Edinburgh, 1991.
SITTIG M., in Pharmaceutical manufacturing encyclopedia, NOYES data corp.,
Parkridge, USA, 1979.
BEYER W.F. et JENSEN E.H., Tolbutamide, in Analytical profiles of drugs (K. FLOREY,
edit.) volume 3 513-541, Additif ibid volume 5,719-734, Errata ibid volume 65, 557.
TAKLA P.G., Glibenclamide in Analytical profiles of drugs (K. FLOREY, edit.) 10, 337-
355.
The Merck index, XIe édition, Merck & Co, Rahway (N.J.) 1989.
Spectrométrie de masse
BELVEDERE G., FANELLI R., FRIGERIO A, MALEN A. et HUGON P., Mass spectro-
metnc identification of the thermal décomposition of /V-(p-toluenesulfonyl)-/V'-[aza-
bicyclo(3.3.0.)octyl]urea (S-852). J. Chromatogr. Sci., 1975, 13, 54-56.